Roche Holding AG (ROG.VX) Chief Executive Severin Schwan said Wednesday the company plans to launch a bond to help finance the planned takeover of...
Swiss pharmaceutical company Roche AG (ROG.VX) is facing a tough year, the company's Chief Financial Officer Erich Hunziker said in a conference...
Roche Holding AG (ROG.VX) is still very committed to its intention of taking over the minority shareholdings of Genentech Inc. (DNA), Chief...
Roche Holding AG (ROG.VX) Wednesday reported an 8% drop in full-year net profit and slightly lower sales, as the strong Swiss franc and a sharp...
Roche Holding AG (ROG.VX) Wednesday reported a 8% drop in full-year net profit and slightly lower sales, as the strong Swiss franc and a sharp...
Swiss drugmaker Roche Holding AG (ROG.VX) Wednesday reported a 5% drop in net profit for 2008, citing the strong franc and lower financial income...
Reversing an earlier recommendation, the agency that decides which treatments are made available in the publicly funded healthcare system in...
By Peter Loftus Of DOW JONES NEWSWIRES A clearer picture is emerging of which major drug companies might follow the lead of Pfizer Inc. (PFE) and...
Genentech Inc. (DNA) and Roche Holding AG (ROG.VX) said a study examining the potential benefits of combining cancer drugs Tarceva and Avastin was...
Swiss drugmaker Roche Holding AG said Tuesday interim results from a phase III study, ATLAS, in patients with advanced non small cell lung cancer...
U.K. diagnostics company DxS Ltd. Monday said it has licensed its Scorpions technology to chemicals giant DuPont Co. (DD). The license was granted...
Pfizer Inc. (PFE) ended a Phase III study of an experimental drug, axitinib, aimed at shrinking tumors in people with advanced pancreatic cancer...
In a display of hostility toward a firm it mostly owns, Roche Holdings on Friday lowered its takeover bid for Genentech and took the offer...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.